Mr. Graham Farrell reports

CIPHER PHARMACEUTICALS SCHEDULES Q1 2026 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the first quarter of 2026 after the market close on Thursday, May 7, 2026. The company will also hold a conference call on Friday, May 8, 2026, at 8:30 a.m. ET, to discuss the results and corporate developments.

Conference call details

Date:  Friday, May 8, 2026

Time:  8:30 a.m. ET

Dial-in number:  416-945-7677 or 888-699-1199

Replay:  289-819-1450 or 888-660-6345; code 18643 followed by the pound key; expires May 15, 2026

Webcast:  A webcast will be available.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early-to-late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.